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Abstract 
The aim of the present study was to investigate the hormonal regulation of hyaluronan (HA) 
components in sheep granulosa cells. HA components are present in the reproductive tract and have 
a range of physical and signalling properties related to reproductive function in several species. First, 
abattoir-derived ovaries of sheep were used to determine the localisation of HA synthase (HAS) 1–3 
and CD44 proteins in antral follicles. Staining for HAS1–3 and CD44 proteins was most intense in the 
granulosa layer. Accordingly, the expression of HAS2, HAS3 and CD44 mRNA was measured in 
cultured granulosa cells exposed to 0–50 ng mL–1 of 17β-oestradiol and different combinations of 
oestradiol, gonadotropins, insulin-like growth factor (IGF)-1 and insulin for 48–96 h (1 ng mL–1 FSH, 
10 ng mL–1 insulin, 10 ng mL–1 IGF-1, 40 ng mL–1 E2 and 25 ng mL–1 LH.). mRNA expression was 
quantified by real-time polymerase chain reaction using a fold induction method. The results 
revealed that the hormones tested generally stimulated mRNA expression of the genes of interest in 
cultured granulosa cells. Specifically, oestradiol, when combined with IGF-1, insulin and FSH, 
stimulated HAS2 mRNA expression. Oestradiol and LH had synergistic effects in increasing HAS3 
mRNA expression. In conclusion, we suggest that the hormones studied differentially regulate HAS2, 
HAS3 and CD44 in ovine granulosa cells in vitro. Further work is needed to address the signalling 
pathways involved.  
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Introduction 
 
Folliculogenesis proceeds under the coordinated control of systemic gonadotropin hormones and 
locally produced growth factors. Growing follicles become sensitive to gonadotropins in the preantral 
stages, whereas antral follicles become increasingly dependent on gonadotropins. Insulin-like growth 
factor (IGF)-1 mediates the transition from gonadotropin responsiveness to dependency via 
enhancement of gonadotropin receptor expression and stimulation of steroidogenesis (Silva et al. 
2009; Scaramuzzi et al. 2011). Dominant follicles gain ovulatory potential by transition from FSH to LH 
dependency accompanied by an increase in 17β-oestradiol (E2) in the follicular fluid (Campbell et al. 
1999; Fortune et al. 2004; Hunter et al. 2004; Baerwald et al. 2012). 
 
The multiple layers of granulosa cells (GCs) in growing follicles are surrounded by a basal lamina that 
separates them from the theca. This specialised extracellular matrix (ECM) manages fluid dynamics 
and provides mechanical support. Hyaluronan (HA) is an important component of the ECM, present in 
various tissues of many species and contribute to cell signalling pathways as well as to the physical 
characteristics and stability of different cell types (Itano and Kimata 2002; Adamia et al. 2005). In 
addition, HA actively participates in both intra- and extracellular pathways, influencing cellular 
behaviour such as migration, growth, motility, adhesion and differentiation (Toole 2001; Toole et al. 
2002; Bodevin-Authelet et al. 2005; Itano 2008). 
 
Three main isoforms of HA synthases (HAS), namely HAS1, HAS2 and HAS3, are responsible for the 
synthesis of different-sized HA on cell membranes in mammalian tissues and these isoforms have 
55%–71% of amino acid sequences in common in their structures (Weigel and DeAngelis 2007; Itano 
2008; Erickson and Stern 2012; Bernert 2013). Large-sized HA (>2 × 106 Da) is synthesised by HAS2, 
whereas smaller-sized HA (between 2 × 105 and 2 × 106 Da) are synthesised by HAS1 and HAS3 (Itano 
and Kimata 2002). Small-size HA has functional roles that include immune stimulatory, inflammatory 
and angiogenic effects, as well as induction of CD44 cleavage (Stern 2004). Large-size HA has mainly 
structural roles, such as water absorbance and space filling. These characteristics of large HA support 
the role of the ECM in maintaining tissue integrity, together with its functional roles as an anti-
angiogenic, immune-suppressive and anti-apoptotic factor (Stern 2004). Indeed, production of large-
size HA by HAS2 in ovarian follicles has been linked to lack of vascularisation in the GCs due to blockade 
of endothelial cell migration and proliferation (Temple et al. 2000). 
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Various elements of the HA system are present in different parts of the reproductive tract. For 
example, HAS was detected using immunohistochemistry in pig ovary (Miyake et al. 2009), ovine cervix 
(Perry et al. 2012) and uterus (Raheem et al. 2013) and human endometrium (Nykopp et al. 2010). In 
addition, the HA receptor (CD44) was immunolocalised in ovine cervix (Perry et al. 2010) and uterus 
(Raheem et al. 2013), pig ovary (Miyake et al. 2006) and oviduct (Tienthai et al. 2003), bovine oocytes, 
embryos and oviduct (Ulbrich et al. 2004; Marei et al. 2012; Marei et al. 2013), cumulus and mural 
granulosa (Ohta et al. 1999; Marei et al. 2012) and cervical cells (El Maradny et al. 1997). 
 
The main HA-binding proteins, so called hyaladherins, are CD44 and receptor for Hyaluronan-
mediated motility (RHAMM) (Laurent et al. 1995; Toole 2004). The CD44 receptor has three domains, 
of which the second interacts extracellularly with both large and small HA (Marzioni et al. 2001; 
Bernert 2013). Interaction of HA with its main receptor (CD44) influences cellular activities such as cell 
migration, proliferation and differentiation (Bernert 2013). 
 
The control of HA synthesis, utilisation and degradation in reproductive tissues has been studied to 
some extent, but has not been fully characterised. In the present study, we hypothesised that the 
hormones tested may control HA synthesis via mediation of HAS, particularly HAS2 and HAS3, in sheep 
GCs.  
 
Materials and methods 
 
Experimental design 
Experiment 1 investigated the presence of different isoforms of HAS (HAS1, HAS2, HAS3) and 
hyaluronan receptor (CD44) by immunohistochemistry in follicles of sheep ovaries collected from a 
local abattoir at different stages of the oestrous cycle during the breeding season. 
 
Experiment 2 aimed to study the role of E2 in regulating HA synthesis in sheep GCs. Serum-free GC 
cultures were treated with different concentrations of E2 (0, 3.12, 12.5, 25 and 50 ng mL–1). 
Expression of HAS2, HAS3 and CD44 mRNA was measured after 24, 48, 72 and 96 h exposure using 
real-time polymerase chain reaction (PCR). 
 
Experiment 3 aimed to test the effects of different reproductive hormones (gonadotropins and E2), as 
well as insulin and IGF-1, on the expression of HAS2, HAS3 and CD44 mRNA. Cultured GCs were treated 
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with different combinations of 1 ng mL–1 FSH, 10 ng mL–1 insulin, 10 ng mL–1 IGF-1, 40 ng mL–1 E2 
and 25 ng mL–1 LH. HAS2, HAS3 and CD44 mRNA expression was measured after 48 h culture. 
 
In Experiments 2 and 3, gene expression was compared between cells harvested from basic culture 
medium only (control) and those cells for which the basic culture medium was supplemented with 
individual hormones or combinations at the stated concentrations. 
 
Chemicals and reagents 
Unless stated otherwise, reagents were purchased from Sigma-Aldrich (Gillingham, UK). 
 
Immunohistochemistry 
For detection of HAS1, HAS2, HAS3 and CD44, ovaries collected from the abattoir were fixed 
immediately in 4% formalin, pH 7.0 (VWR, Leicestershire, UK), for 48 h, then embedded in paraffin 
wax using a standard automated procedure. Sections (5 µm) were mounted on ‘Superfrost’ slides 
(VWR) and then dewaxed in histoclear III (AGTC Bioproducts Ltd, Hessle, UK) for a maximum of 2 h, 
followed by rehydration in an ethanol gradient series. 
 
Rehydrated sections were washed twice in distilled water for 5 min each time, followed by antigen 
retrieval in Tris-EDTA buffer containing 10 mM Tris base (Bio-Rad, Hemel Hempstead, UK) and 1 mM 
EDTA (pH 9). Antigen retrieval involved incubating sections in boiled Tris-EDTA buffer for 25 min. 
Endogenous peroxidase activity was quenched by applying 3% v/v H2O2 in phosphate-buffered saline 
(PBS) for 15 min. Slides were then incubated in 0.25% NH4Cl in PBS for 15 min before being washed 
in distilled water. Non-specific binding was blocked by incubation for 1 h in 5% normal horse serum, 
obtained from the species in which the secondary antibody was raised. The normal serum was diluted 
in buffer containing 1× Tris-buffered saline (TBS), 0.1% w/v gelatin, 0.1% v/v Triton X-100 and 0.05% 
v/v Tween 20. The composition of the 1× TBS was 0.05 M Tris base (Bio-Rad) and 0.9% NaCl (pH 7.6). 
 
Sections were overlaid with rabbit polyclonal anti-human HAS2 (Santa Cruz, Dallas, TX, USA), HAS3 
(Santa Cruz), HAS1 (Abgen, San Diego, CA, USA) or mouse anti-human CD44v6 monoclonal (AbD 
Serotec, Kidlington, UK) primary antibodies overnight in a humidified chamber at 4°C. The anti-HAS 
antibodies were used at a dilution of 1 : 50 dilution and the anti-CD44 antibody was diluted 1 : 100 in 
TBS with Tween 20 (TBST). 
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The next day, sections were washed twice in TBST for 5 min each time. Horseradish peroxidase-
conjugated polyclonal pig anti-rabbit (Dako UK Ltd, Ely, Cambridgeshire, UK) and rabbit anti-mouse 
(Dako) IgGs were used as secondary antibodies. Secondary antibodies (1 : 200 dilution in PBS) were 
applied for 1 h at room temperature; slides were then washed in PBS, pH 7.4, for 5 min. 
 
Signals from HAS1, HAS2, HAS3 and CD44 proteins were visualised with 3,3′-diaminobenzidine (liquid 
DAB+ substrate, chromogen system; Dako). The slides were counterstained in 10% Harris 
haematoxylin for 20 s and then washed under running water to remove excess stain from the slides. 
Finally, the slides were dehydrated in a gradient of ethanol before being mounted under a coverslip 
(VWR) with hard-setting DPX mounting medium (VWR). 
 
Semiquantitative analysis of immunostaining 
Immunostaining was assessed semiquantitatively using a histochemical score (H-score) system, 
ranging between 0 and 300, as described previously (Raheem et al. 2013), where a score of 0 
corresponds to no staining and a score of 300 corresponds to maximum staining. 
 
GC isolation for culture 
Sheep ovaries were collected during the breeding season (October, November and December) from a 
local abattoir. Ovaries were transported to the laboratory within 1 h at 37°C in PBS. Intact ovaries 
were washed three times with PBS before and then again after one rinse with 70% ethanol. Thereafter, 
the ovaries were maintained in PBS containing 100 U mL–1 penicillin and 100 µg mL–1 streptomycin 
at 37°C during processing. GCs were collected by aspiration of healthy follicles within the 2–4 mm 
diameter range. Follicular fluid was aspirated using a 23-gauge needle mounted on a 10-mL syringe. 
The aspirate was passed through a 100-µm cell strainer to remove debris and oocytes; the resulting 
cell suspension was then centrifuged at 800g for 10 min. Erythrocyte contamination was removed by 
resuspending the cell pellet in 1 mL sterile water followed immediately by the addition of 20 mL 
McCoy’s 5A medium to readjust osmolarity. The cell suspension was centrifuged at 800g for 5 min and 
resuspended in 1 mL culture medium as described below. 
 
GC culture 
The yield of viable cells was counted using Trypan blue exclusion on a haemocytometer. Cultures were 
set up containing 100 000 cells per well in 96-well plates. The culture plates were incubated at 37°C in 
a humidified atmosphere of 5% CO2 in air. Culture media were changed every second day and cultures 
were maintained for up to 96 h. The basic medium used for GC culture was McCoys 5A medium, 
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containing 20 mM HEPES, 100 U mL–1 penicillin, 100 µg mL–1 streptomycin, 2 mM l-glutamine, 2.5 µg 
mL–1 holotransferrin, 4 ng mL–1 sodium selenite and 1 mg mL–1 bovine serum albumin (BSA; 
Campbell et al. 1996; Allegrucci et al. 2003). This basic medium, including 1 ng mL–1 FSH and 10 ng 
mL–1 insulin, was used for control cultures. Where required for test samples, the medium was 
supplemented with individual hormones or combinations, as follows: for Experiment 2, E2 (0, 3.12, 
12.5, 25, 50 ng mL–1); for Experiment 3, 1 ng mL–1 FSH, 10 ng mL–1 insulin, 10 ng mL–1 IGF-1, 40 ng 
mL–1 E2 and 25 ng mL–1 LH. The expression of HAS2, HAS3 and CD44 mRNA was determined after 
48h culture. 
 
Assessment of GC viability, proliferation and luteinisation 
The viability of freshly isolated GCs was checked by the Trypan blue exclusion test before culture. GC 
proliferation in vitro was monitored by the cell Titer96 Aqueous one solution cell proliferation assay 
(Promega, Madison, WI, USA) according to the manufacturer’s instructions. Briefly, in a 96-well plate, 
20 µL cell titre solution was mixed with 100 µL fresh culture medium per well and incubated for 4 h at 
37°C in a humidified atmosphere containing 5% CO2. This assay uses formazan to determine the 
number of viable cells at the time of culture termination. Tetrazolium salt reduction to formazan was 
detected at a wavelength of 490 nm using a microplate reader (Tecan, Reading, UK). 
 
GC luteinisation was checked using radioimmunoassay (RIA) analysis of spent culture medium at 48 
and 96 h to measure E2 and progesterone production, as described by Robinson et al. (2002). For GC 
cultures in Experiments 2 and 3, the concentrations of FSH and insulin applied were those that, in 
preliminary experiments, together resulted in an approximate 1 : 1 ratio of secreted E2 : progesterone 
throughout the culture period. 
 
RNA isolation and reverse transcription 
Culture medium was removed and cultured GC were washed using sterile PBS on ice. Total RNA was 
extracted through RNeasy Mini Kit columns (Qiagen, West Sussex, UK) according to the 
manufacturer’s instructions. The concentration and purity of the isolated RNA samples was 
determined using an Infinite 200 NanoQuant (Tecan, Reading, UK). All samples had an absorbance at 
260 : 280 nm (A260/280) ratio between 1.9 and 2.1. RNA integrity was evaluated using formaldehyde 
gel to determine the presence of intact 18S and 28S bands. Total RNA (500–1000 ng) was treated for 
potential genomic DNA carryover in a single reaction in accordance with the guidelines supplied by 
DNase (Promega, Southampton, UK). DNase-treated RNA was reverse transcribed using random 
hexamer primers and processed accordingly (Reverse Transcription System Kit; Promega). 
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Primer design and real-time PCR 
Sequences of the genes of interest (HAS2, HAS3, CD44) and the housekeeping gene (β2 microglobulin, 
B2M) were obtained from GenBank published in the National Centre for Biotechnology Information 
(NCBI) database (http://www.ncbi.nlm.nih.gov/gene). Primer sequences were designed online using 
primer3 web software (http://frodo.wi.mit.edu/primer3/input.htm, accessed 25 February 2011). 
Primer alignment specificity was checked using the BLAST search tool 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi?PROGRAM=blastn&PAGE_TYPE=BlastSearch&LINK_LOC=blas
thome). Sequence information, accession numbers and expected product lengths, together with the 
running conditions, are given in Table 1. All oligonucleotides were commercially synthesised as highly 
purified salt-free products (MWG-Biotech, London, UK). The primers of each gene were tested by 
conventional PCR amplification using a Multiplex PCR kit (Qiagen), 25 ng cDNA and 0.5 µM primers. 
For each real-time PCR assay, the master mix contained a final concentration of 1× relative qPCR SYBR 
Green Mix (AB gene, Epsom, UK). The optimal annealing temperature (resulting in minimal threshold 
cycle (Ct)) was determined using the temperature gradient function of the real-time PCR machine 
(qPCR; CFX 96 Real-Time PCR Detection System; Bio-Rad) using identical reactions with control cDNA 
samples. A melting curve analysis was performed for each amplicon between 50°C and 95°C and the 
reading temperature was set so that any smaller non-specific products, such as dimers, were melted 
(if present) before fluorescence acquisition. The unknown cDNA samples (equivalent to 25 ng reverse-
transcribed RNA) were amplified in duplicate in the same assay using a master mix containing 1× KAPA 
SYBR green mix (Anachem, Boston, MA, USA), forward and reverse primer mix (0.5 µM) and nuclease-
free water in 20 µL reactions. Thermal cycling conditions applied to each assay consisted of an initial 
taq activation at 95°C for 15 min, followed by 38 cycles of denaturation (95°C for 30 s), annealing (61°C 
and 59°C for 30 s) for genes of interest and the housekeeping gene and extension (72°C for 20 s). A 
no-template control (NTC) was included on every plate for each set of primers. To minimise variation, 
all samples included in each analysis were derived from the same reverse transcription batch, 
prepared under the same conditions, and were analysed on a single plate in duplicate. The Ct values 
for unknown samples were obtained using a real-time PCR machine (Bio-Rad). Relative quantified 
expression of the genes evaluated across treatments was measured by comparing the Ct values of the 
gene of interest against that of the housekeeping gene using the ΔΔCt method (Hettinger et al. 2001; 
Luo and Wiltbank 2006). 
 
Statistical analysis 
In all experiments, data points were determined from at least three independent experiments. Gene 
expression data were analysed using SPSS version 19 (IBM United Kingdom Limited, Portsmouth, UK) 
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using a linear mixed model. If the treatment effect was significant, least significance difference (l.s.d.) 
tests were performed. Data are plotted as the mean ± s.e.m. Two-tailed P ≤ 0.05 was considered 
significant. P-values between >0.05 and 0.1 were considered to indicate a non-significant tendency. 
Effects of treatment were compared with control at each time point individually, based on the mean 
fold change in mRNA level. 
 
Results 
Immunohistochemistry of the HA system in sheep ovarian follicles 
As shown in Fig. 1a, HAS1, HAS2, HAS3 and CD44 proteins were present in the antral follicles. In 
addition, the intensity of HAS and CD44 immunostaining in the theca cell layer appeared to be less 
than the staining of the GC layer (Fig. 1a). The H-Score values for the corresponding proteins are shown 
in Fig. 2. The H-Score results are approximately double for HAS2 and HAS3 and nearly fourfold higher 
for CD44 presence in the GC layer compared with the theca cell layer. The presence of these proteins 
in stromal cells was negligible compared with follicular cells. There was a tendency for slightly more 
abundant HAS2 protein in the GC layer than HAS1 or HAS3 protein. There were no obvious differences 
in levels of HAS isoform proteins in the theca cell layer of antral follicles. The presence of CD44 in the 
theca cell layer was negligible. 
 
Fig. 1b shows results obtained in the negative controls using rabbit and mouse IgG. The negative 
control for rabbit IgG was free from non-specific binding, whereas mouse IgG showed some non-
specific staining in the follicular fluid and at the endothelial cells of blood vessels in particular. 
Therefore, CD44 staining in follicular fluid and endothelial cells was considered to be an artefact; 
however, CD44 staining observed in GC and theca cell layers was considered reliable because the 
negative control slides were always negative in these areas. 
 
Effects of different concentrations of E2 on HAS2 mRNA expression in cultured GC 
Treatment of GC cultures with E2 resulted in increased HAS2 expression. However, the timing of this 
effect varied according to the concentration of E2 used. At the lowest concentration (3.12 ng mL–1) 
the increase in HAS2 expression was only evident after 96 h, whereas HAS2 expression in GC treated 
with higher concentrations of E2 (12.5–50 ng mL–1) increased at 48 h culture, then decreased 
subsequently at 72 and 96 h (P < 0.05; Fig. 3). When the effect of E2 (regardless of concentration) on 
HAS2 was analysed statistically, a significant (P < 0.05) increase in HAS2 expression was evident at 48 
h compared with 24 h (Fig. 4). 
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Effects of different concentrations of E2 on HAS3 mRNA expression in cultured GC 
The effect of E2 on HAS3 expression was highly variable among different experimental replicates. 
HAS3 expression increased gradually with time and was significantly higher at 96 h than at 24 h after 
treatment with 12.5 and 50 ng mL–1 E2 (P < 0.05; Fig. 3). When the effect of E2 (regardless of 
concentration) on HAS3 was analysed statistically, no significant effect was detected at 48 h compared 
with 24 h (Fig. 4). 
 
Effects of different concentrations of E2 on CD44 mRNA expression in cultured GC 
The effect of E2 on CD44 was less marked and was not consistent among different concentrations of 
E2. An approximate 0.4-fold increase in CD44 mRNA expression was observed after 96 h compared 
with expression at 24 h in cells treated with 3.1 and 25 ng mL–1 E2, as well as at 48 h in cells treated 
with 12.5 ng mL–1 E2 (P < 0.05; Fig. 3). When the effect of E2 on CD44 was analysed regardless of the 
E2 concentration, a significant (P < 0.05) increase in CD44 expression was evident at 48 h compared 
with 24 h (Fig. 4). 
 
Effects of FSH, LH, IGF-1, insulin and E2 on HAS2, HAS3 and CD44 expression HAS2 
As shown in Fig. 5, compared with control, IGF-1 tended (P = 0.058) to increase HAS2 expression at 48 
h in culture, with insulin showing a similar tendency. FSH or LH alone did not significantly change HAS2 
expression; however, the combination of FSH and insulin tended (P = 0.057) to increase HAS2 
expression. The combination of FSH + IGF-1 significantly increased HAS2 expression compared with 
control. 
 
In the presence or absence of FSH or LH, E2 did not significantly alter HAS2 expression, whereas the 
combination of E2 and FSH together with insulin, in the presence or absence of IGF-1, significantly 
increased HAS2 expression compared with control and the FSH + E2-treated group. However, the 
addition of IGF-1 to this combination (i.e. insulin + FSH + E2) triggered a significant increase in HAS2 
mRNA expression compared with control, FSH + E2 and FSH + insulin treatment. 
 
HAS3 
As shown in Fig. 5, LH + E2 treatment significantly increased HAS3 expression compared with all other 
treatments (including control) but excluding the combination of FSH + insulin + E2. All treatments 
except for the combination of LH + E2 had an effect similar to control and did not significantly change 
HAS3 expression. Further, the FSH + insulin + E2 treatment had a tendency to increase HAS3 
expression compared with FSH + IGF-1 (P = 0.055) and insulin (P = 0.071) treatments. Although neither 
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LH nor E2 changed HAS3 expression independently, their combination (i.e. LH + E2) increased HAS3 
expression compared with the effect either treatment alone. 
 
CD44 
As shown in Fig. 5, E2 and insulin significantly increased, whereas IGF-1 (P = 0.071) and FSH (P = 0.060) 
had a tendency to increase, CD44 expression compared with control. Interestingly, compared with 
control, E2 in the presence of FSH or insulin significantly increased CD44 expression, whereas the 
combination of E2 + FSH + insulin tended (P = 0.065) to increase CD44 expression to a similar extent. 
In addition, FSH + IGF-1 tended (P = 0.054) to increase CD44 expression compared with control. 
Further, LH in the presence or absence of E2 significantly increased CD44 expression compared with 
control. The combination of E2 with other factors, excluding IGF-1, generally had an effect on CD44 
expression that was similar to that of E2 alone. Compared with FSH alone, the combination of either 
IGF-1 or insulin together with FSH did not change CD44 mRNA expression. The combination of FSH + 
IGF-1 + insulin + E2 significantly decreased CD44 expression compared with E2 in the presence or 
absence of LH. 
 
Discussion 
The present study has shown, for the first time, the presence of HAS isoforms and CD44 protein in 
ovine ovaries and has further demonstrated, in a GC culture model system, that expression of HAS2, 
HAS3 and CD44 is significantly stimulated by certain reproductive hormones acting alone or in 
combination. 
 
HA is recognised as a cell signalling molecule that has effects on cell cascades, such as migration and 
proliferation, through interactions with cell surface receptors (Kosaki et al. 1999; Camenisch et al. 
2000; Lee and Spicer 2000; Necas et al. 2008). Synthesis of HAS3 restricts the availability of HAS 
substrate (uridine diphosphate (UDP)) for the other HAS enzymes (Kultti et al. 2009). Of the three HAS 
isoforms (i.e. HAS1, HAS2, HAS3), HAS3 is the most resilient to UDP constraint (Rilla et al. 2013), 
whereas HAS1 is more sensitive to sugar shortage than HAS2 and HAS3. Both the precursor of E2 
(cholesterol) and HAS substrate (UDP) originate from the phospholipid compartment of the cell 
membrane. 
 
The H-Score data (Fig. 2) in the present study revealed that the intensity of HAS and CD44 staining was 
greater in GCs than in theca cells in antral follicles. HA, as a component of the follicular fluid (Saito et 
al. 2000; Ohta et al. 2001), is known for its role in cumulus cell expansion. Therefore, the presence of 
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HAS isoforms in GCs is not surprising. However, the parallel presence of the CD44 receptor was not 
previously appreciated. This may underlie a range of effects of HA in the reproductive system, possibly 
facilitating the close control of synthesis and degradation of different lengths of HA molecules in 
follicles at different stages of development and in different phases of the reproductive cycle. Further 
investigation of HAS and CD44 intensity in follicular cells of oestrus synchronised ewes may shed 
further light on the factors influencing the protein content of antral follicles. 
 
The HAS isoforms are responsible for the production of different lengths of HA (Itano et al. 1999; Itano 
and Kimata 2002). Therefore, we consider that coordination between the ratio of HAS enzymes and 
their products to CD44 in sheep follicles is important in order to accumulate HA in an appropriate and 
timely manner as the antral follicle approaches ovulation. Positive staining was observed for HAS2 and 
HAS3 in the blood vessels and stromal layer of ovarian sections in the present study. HAS isoforms and 
CD44 expression in human and rat vascular smooth muscle, respectively, have been reported 
previously (Jain et al. 1996; Sainio et al. 2010; Freudenberger et al. 2011). 
 
Having demonstrated the presence of HA synthesis and signalling components, we wanted to 
understand the hormonal regulation of HAS and CD44 in the ovary. Therefore, we studied the 
expression of these components in response to several endocrine signals in a model system, namely 
GC culture. 
 
The present study has shown that E2 significantly stimulates the expression of HAS2 and CD44 over a 
48 h culture period (Fig. 4). The concentrations of E2 selected for experimentation fall within the 
physiological concentrations in follicular fluid (Tsonis et al. 1984). Oestradiol receptor (ER) β is present 
in GCs (Hall et al. 2001; Jacob et al. 2006; Juengel et al. 2006; Deroo et al. 2009). Not only does ERβ 
interact with ERα, but it also regulates cell signalling cascades associated with E2 (Pettersson et al. 
1997; Koehler et al. 2005; Galluzzo et al. 2007; Zhao et al. 2008). 
 
There is a complex feedback system associated with the synthesis and signalling of HA and E2, which 
may explain why the effects observed in our cultures were quite variable. For example, E2 stimulates 
many intracellular cascades involving phosphatidylinositol 3-kinase and mitogen-activated protein 
kinase (MAPK). Conversely, MAPKs affect steroidogenesis by regulating steroidogenic acute regulatory 
protein (StAR) expression (Moriarty et al. 2006; Watson et al. 2012; Manna and Stocco 2011). Similarly, 
the presence of gonadotropins (FSH or LH) plus E2 enhanced both HAS2 and HAS3 expression in our 
cultures. Gonadotropins have been reported to enhance HAS2 mRNA expression in bovine cumulus–
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oocyte complexes (Schoenfelder and Einspanier 2003). This suggests that the pathway controlling 
HAS2 and HAS3 may have a link to E2 or gonadotropin pathways. 
 
There was no substantial effect of the treatments evaluated on CD44 expression in our culture system. 
It seems that CD44 expression may be associated with the level of HA production rather than HAS 
expression (Nykopp et al. 2009). 
 
The results of the present study indicate that insulin and IGF-1 are more effective than FSH and E2 at 
enhancing HAS2 expression. The effects of LH on HAS3 expression surpassed those of insulin and FSH, 
and LH enhanced the effects of E2 in combination with insulin and FSH on HAS3 expression. Therefore, 
LH has the predominant effect on HAS3. In addition, the results of the present study indicate that E2 
is an important hormone regulating CD44 expression in sheep GC because E2 enhanced the effect of 
FSH on CD44 whereas insulin did not. We postulate that IGF-1, LH and E2 are the decisive factors in 
HAS2, HAS3 and CD44 expression, respectively. In addition, insulin seems to be a codeterminant of 
HAS2 and CD44 expression. 
 
Together, the results of the present study indicate that endocrine control of some HA system 
components (HAS2, HAS3 and CD44) in sheep GCs occurs in a discrete and potentially 
complementary manner. This work promotes the idea that HA is not solely a physical component of 
the follicle, but that its signalling role is affected by factors that control female reproduction. The 
details of HA’s signalling capacity remain to be elucidated.
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Table 1.  Oligonucleotide primer sequences and amplicon sizes, and their corresponding annealing 
and plate reading temperatures, used for quantitative polymerase chain reaction assays 
HAS, hyaluronan synthase; B2M, beta 2 microglobulin 
 
Gene Primer sequence (5’-3’) Size 
(bp) 
Accession no. Temp (°C) 
Annealing  
Temp (°C)  
Reading 
HAS2 Forward: GGGGGAGATGTCCAGATTTT 
Reverse: ATGCACTGGACACATCCGA 
125 NM174079 61 74 
HAS3 Forward: ACAGGTTTCTTCCCCTTCTTCC 
Reverse: GCGACATGAAGATCATCTCTGC 
166 NM001192867.1 61 78 
CD44 Forward: TATAACCTGCCGATATGCAGG 
Reverse: CAGCACAGATGGAATTGGG 
221 NM174013.3 61 80 
B2M Forward: CGCCAGAAGATGGAAAGC 
Reverse: GAACTCAGCGTGGGACAGA 
167 NM001009284.1 59 76.5 
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Fig. 1.  Immunohistochemical localisation of hyaluronan synthase (HAS) isoforms (HAS 1–3) and the 
HAS receptor (CD44) in ovine antral follicles. (a) Localisation of HAS1, HAS2, HAS3 and CD44. The 
intensity of staining is greatest for HAS2, followed by HAS3 and then HAS1. Staining is more intense in 
the granulosa cell (GC) layer than the theca cell layer. Some staining is apparent in the endothelial 
layer of blood vessels and the follicular fluid. TCE, theca cell externa; TCI. theca cell interna. (b) 
Negative controls using rabbit and mouse IgG. Note some staining of endothelial cells of blood vessels 
and the follicular fluid in the mouse IgG control. Theca cells and GCs were not stained in the negative 
controls. 
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Fig. 2.  Semiquantitative measurement of hyaluronan synthase (HAS) isoforms (HAS 1–3) and CD44 
proteins immunolocalised in ovine antral follicles using the histochemical score (H-Score) system. Data 
are given as the mean ± s.e.m. The significance of differences in mean values was evaluated using t-
tests (independent sample). Columns with different letters differ significantly (P < 0.05). 
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Fig. 3.  Hyaluronan synthase (HAS) 2, HAS3 and CD44 expression in granulosa cells in the presence of 
3.1, 12.5, 25 and 50 ng mL–1 17β-oestradiol (E2). Data are the mean ± s.e.m. The significance of 
differences in mean values was evaluated using a linear mixed model followed by l.s.d. pairwise 
comparison. For each concentration of E2, values with different letters differ significantly (P < 0.05). 
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Fig. 4.  Hyaluronan synthase (HAS) 2, HAS3 and CD44 expression in granulosa cells in response to 17β-
oestradiol (E2) supplementation. Data are the mean ± s.e.m. The significance of differences in mean 
values was evaluated using a linear mixed model. Columns with different letters differ significantly (P 
< 0.05). 
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Fig. 5.  Effects of FSH, insulin, insulin-like growth factor (IGF)-1, 17β-oestradiol (E2) (1 ng mL–1 FSH, 
10 ng mL–1 insulin, 10 ng mL–1 IGF-1, 40 ng mL–1 E2 and 25 ng mL–1 LH) and their combination on 
hyaluronan synthase (HAS) 2, HAS3 and CD44 expression in granulosa cells cultured for 48 h. Data 
are the mean ± s.e.m. The significance of differences in mean values was evaluated using a linear 
mixed model. Columns with different letters differ significantly (P < 0.05). 
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